# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-016003
Filing Date
2024-05-10
Accepted
2024-05-10 16:06:40
Documents
5
Period of Report
2024-06-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | aytu20240409_def14a.htm | DEF 14A | 573831
2 |  | aytuproxy01.jpg | GRAPHIC | 259420
3 |  | aytuproxy02.jpg | GRAPHIC | 179711
4 |  | netloss2.jpg | GRAPHIC | 206704
5 |  | tsr.jpg | GRAPHIC | 207386
| Complete submission text file | 0001437749-24-016003.txt |  | 1750129

Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-38247 | Film No.: 24934846
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)